# Naloxone {#id}

Pure opioid antagonist used predominantly for opioid overdose.

|Property|Drug
|--|--|
|**Class**|**μ-**, κ-, δ- opioid receptor competitive antagonist
|**Uses**|Opioid overdose
|**Presentation**|
|**Route of Administration**|IV, IM
|**Dosing**|0.1-0.4mg Q5min
|**Absorption**|Very high first pass metabolism leading to minimal PO bioavailability
|**Distribution**|50% protein bound
|**Metabolism**|Hepatic metabolism
|**Elimination**|Renal eliminiation
|**Resp**|↑ RR, ↑ V<sub>T</sub>
|**CVS**|↑ SVR & ↑ BP, arrhythmia
|**CNS**|↓ analgesia, ↓ sedation, ↓ miosis
|**Other considerations**| Duration of action is ~30-40 minutes is shorter than some opioids, which may lead to re-narcosis if not given subsequent doses or by infusion

---
##References
Peck and Hill
Smith Scarth Sasada